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Abstract
● AIM: To assess the inter-observer agreement and reliability 
as well as intra-observer repeatability for lacrimal 
scintigraphy (LS) reports with and without considering the 
irrigation test results.
● METHODS: A prospective, observational, cross sectional 
study. Two masked clinicians (lacrimal surgeon and nuclear 
medicine specialist) independently reported 100 LS images 
(50 patients of >6 years of age with unilateral anophthalmic 
socket) in a university hospital. The lacrimal surgeon 
performed a diagnostic irrigation test and repeated the 
report of the same LS images 2y after the first report 
(intra-observer agreement). A weighted Kappa analysis 
was performed to determine inter-observer agreement 
and reliability as well as intra-observer repeatability for 
the type (normal, partial and complete obstruction) and 
location (presac, preduct, and intraduct) of the obstruction. 
Subgroup analysis was also performed with consideration 
of irrigation test results. 
● RESULTS: A significantly moderate agreement was 
found between lacrimal surgeon and nuclear medicine 
specialist for both the type (Kappa=0.55) and location 
(Kappa=0.48) of obstruction. Agreement values were 
higher for the type (Kappa=0.61 vs 0.41) and location 
(Kappa=0.56 vs 0.31) of obstruction in cases with normal 
than abnormal irrigation test. Strong and significant intra-
observer (lacrimal surgeon) repeatability was found for 
both the type (Kappa=0.66) and location (Kappa=0.69) of 
obstruction. LS showed no to slight reliability based on 
irrigation test.
● CONCLUSION: A moderate agreement is found between 
lacrimal surgeon and nuclear medicine specialist regarding 
the interpretation of LS suggesting the importance of 
consensus groups among nuclear medicine specialists 
and lacrimal surgeons to create a common language for 
interpretation of LS. Intra-observer repeatability is strong 
for the lacrimal surgeon.
● KEYWORDS: epiphora; lacrimal drainage; lacrimal 
scintigraphy; reliability; agreement
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INTRODUCTION
T he lacrimal drainage system (LDS) is a mucous membrane-lined conduit, the function of which depends on 
a complex interplay of anatomy and physiology. Appropriate 
drainage of tears depends on several factors, including normal 
pump mechanisms and anatomic status of the drainage 
passages[1-2]. Epiphora is one of the common complaints of 
patients in ophthalmology clinic[3]. Patients presenting with 
epiphora may have a partial (stenosis) or complete obstruction 
of LDS[4-6]. LDS assessment and tests are necessary steps 
towards the best possible management[3,6-8]. Tests are for the 
assessment of LDS anatomy (diagnostic probing and irrigation 
test) and physiology [fluorescein dye disappearance test 
(FDDT) and lacrimal scintigraphy (LS)][3,5]. Previous studies 
have shown that the results of irrigation test are not always 
consistent with LS and different results could be found in more 
than half of the symptomatic patients[9-10].
FDDT is a simple and useful screening test in assessment of 
the patients with nasolacrimal duct obstruction even though 
it cannot differentiate an anatomical from a physiological 
obstruction[3,7]. While diagnostic probing and irrigation 
test is the gold standard for diagnosis of anatomical 
obstructions[2-3,7,11-12], LS is mostly requested for the patients 
with patent LDS on irrigation test in which stenosis and/
or lacrimal pump impairment are assessed[13]. However, 
previous studies have found considerable variation in the 
technique, normative data, and interpretation of LS[13-15]. It 
is not unusual to encounter conflicting results of LS with 
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patients’ complaints[13,15]. Therefore, its exact value on making 
an accurate decision is unclear[14]. LS images do mostly come 
along with a nuclear medicine specialist’s report which, to our 
experience, has a significant impact on clinicians’ (especially 
comprehensive ophthalmologists) management plan. On the 
other hand, lacrimal surgeons are mostly relying on their own 
interpretation of the images without considering the attached 
report. Therefore, subsequent management plan might be 
different. 
Currently it is not clear how similar the interpretation of LS is 
between the nuclear medicine specialist and lacrimal surgeon 
(inter-observer agreement) and if ophthalmologists and other 
involved clinicians should rely on the attached report or consult 
to a lacrimal surgeon before making any decision regarding the 
presence and location of obstruction in the LDS. It is also not 
clear if the same observer’s report will be the same in different 
times (intra-observer agreement).
Therefore, this study was aiming to assess the agreement[16] 
between a lacrimal surgeon (Kashkouli MB) and nuclear 
medicine specialist (Hedayati R) on LS report regarding both 
the type (normal, partial obstruction, complete obstruction) 
and anatomical location of the obstruction (presac, preduct, 
intraduct) in general and in the subgroup of patients with 
normal versus abnormal lacrimal irrigation test, to evaluate 
intra-observer repeatability[16] for the lacrimal surgeon’s 
reports at different times, and to assess the reliability[16] of LS 
considering the lacrimal irrigation test results.  
SUBJECTS AND METHODS
Ethical Approval  The study was approved by the Ethics 
Committee of Iran University Eye Research Center 
(21471/124/01/92) and informed consent was obtained from all 
the subjects. This study adhered to the tenets of the Declaration 
of Helsinki.
Initially, 100 LS and irrigation test data were extracted from 
our previous prospective study[17] on 50 patients (>6 years old) 
with unilateral anophthalmic socket which was carried on at 
a university hospital (Rassoul Akram Hospital) between 1st of 
March 2013 and 1st of February 2014. Included were subjects 
with more than 6 years of age (to cooperate with the tests) 
who attended the oculofacial plastic clinic for regular checkup. 
Excluded were the patients with previous ocular or periocular 
surgery, history of systemic diseases affecting the eye or ocular 
surface, long term use of any eye drop, and active infection or 
inflammation of the eye or ocular adnexa on the normal eye 
and LDS and or eyelid problem on the anophthalmic socket side.
Patients were referred to the nuclear medicine department, 
had LS test, and handed over the images and reports (nuclear 
medicine specialist reports) to the lacrimal clinic secretary. 
A masked examiner (Kashkouli MB) performed a diagnostic 
probing and irrigation test[18]. All the LS images were then 
interpreted and reported by the same masked observer 
(Kashkouli MB) at the end of the previous study[17] in February 
2014. The second report was made by the same lacrimal 
surgeon (Kashkouli MB) more than 3y after the first report 
(September 2017) for assessment of intra-observer variation. 
The second report of lacrimal surgeon was not presented in 
previous article. To avoid duplication of data, only the results 
of reliability and agreement analyses will be presented here. 
Patients sat upright in front of a gamma camera equipped 
with a low-energy, high-resolution collimator (E. Cam, 
Siemens, Erlangen, Germany) with dual head fixed in an 
adjustable stand. The distance of the cornea to the surface 
of the collimator was less than 20 mm. The tracer study was 
started after instillation of approximately 3.7 MBq (0.1 mCi) 
of Tc-99m pertechnetate in a saline solution per eye with an 
eyedropper. Patients were instructed to continue blinking 
normally and if necessary to blot, not smear tears away with a 
tissue to prevent potential of contamination. Dynamic images 
were then obtained (10s/frame for first 1-2min, followed 
by 1min/frame for remaining time) for 30min. Images were 
acquired without zoom, in a 256×256 matrix. Flushing both 
eyes with saline after the study completion were done to help 
clear remaining radioactivity[6].
The same definitions and interpretation protocol were used 
by two observers. Visual classification was used to report 
both type (normal, partial and complete obstruction) and 
anatomical location (presac, preduct, intraduct) of LDS 
obstruction by two observers who were masked to each 
other’s report. Visualization of the lacrimal sac within 1-3min 
after radioactive administration with drainage of activity 
from the nasolacrimal duct into the nasal cavity within 5min 
was considered as “normal” (Figure 1). Delayed radiotracer 
washout from the lacrimal sac in the presence of some drainage 
of activity after the first 5min of the study was considered 
“partial obstruction” or “stenosis” (Figure 1); and the absence 
of notable radiotracer washout up to the end of the study 
was regarded as “complete obstruction” (Figure 1)[6,9]. The 
anatomical location of obstruction was defined as being either 
presac, preduct, or intraduct. Presac was a hold up of tracer 
at the inner canthus with failure or delay to reach the lacrimal 
sac in first 3min. Preduct was early filling of the lacrimal sac 
but no or delayed visibility of tracer beyond the sac on first 
static image at 5min and “intraduct” was visibility of tracer in 
the upper part of the nasolacrimal duct at 5min but no further 
drainage over the next 15min[15,19] (Figure 1).
Primary outcome measure was the inter-observer agreement 
between lacrimal surgeon and nuclear medicine specialist for 
interpreting LS in general and when considering the results of 
irrigation test. Secondary outcome measures were LS versus 
irrigation test agreement and intra-observer agreement for 
Reliability of lacrimal scintigraphy
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interpretation of LS by the lacrimal surgeon. Each LS was 
considered a case in this study.
All the data were analyzed with MedCalc Statistical Software 
version 13.3.3 (MedCalc Software bvba, Ostend, Belgium; 
http://www.medcalc.org; 2014). Weighted Kappa coefficient 
with 95% confidence interval (CI) was used to examine inter- 
and intra-observer agreements. Linear Cicchetti-Allison 
weights was used in order to measure the weighted Kappa and 
bootstrapped 95%CI was also used.
When interpreting Kappa values, strength of agreement was 
described based on Landis and Koch’s classification[20] which 
includes slight (≤0.20), fair (0.21-0.40), moderate (0.41-0.60), 
substantial (0.61-0.80), and almost perfect (0.81-1.00) agreement. 
A P value of less than 0.05 was considered significant.
RESULTS 
There were 100 LS reports from 50 subjects[17]. 
Agreement Between Lacrimal Surgeon and Nuclear 
Medicine Specialist  Lacrimal surgeon reported a significantly 
(P<0.001) higher frequency of LDS obstruction (47% vs 40%) 
than nuclear medicine specialist. On the other hand, complete 
obstruction was reported more (37/40; 92.9%) by nuclear 
medicine specialist than lacrimal surgeon (28/47, 59.5%; 
P=0.01; Table 1).
Total proportion of agreement on the type of obstruction was 
69% (69/100) comprising 46% normal, 1% partial stenosis, 
and 22% complete obstruction (Table 2). A significant and 
moderate agreement was demonstrated between lacrimal 
surgeon and nuclear medicine specialist for the type of 
obstruction (Kappa=0.55; 95%CI: 0.41-0.7; P<0.001).
Total proportion of agreement on the location of obstruction 
was 69% (69/100) including 46% normal and 23% preduct 
location (Table 3). A significantly moderate agreement was 
demonstrated between lacrimal surgeon and nuclear medicine 
specialist for anatomical location of obstruction (Kappa=0.48; 
95%CI: 0.32-0.62; P<0.001).
Inter-observer Agreement Considering the Irrigation 
Test Results  In subgroup of the cases with normal irrigation 
(n=65), agreement values were substantial and moderate 
for the type (Kappa=0.61; 95%CI: 0.45-0.78; P<0.001) and 
anatomical location (Kappa=0.56; 95%CI: 0.38-0.75; P<0.001) 
of obstruction, respectively. Whereas, in cases with abnormal 
irrigation (n=35), moderate and fair[19] agreement values 
were found between lacrimal surgeon and nuclear medicine 
specialist for both the type (Kappa=0.41;95%CI: 0.16-0.68; 
P=0.002) and anatomical location (Kappa=0.31; 95%CI: 
0.05-0.58; P=0.01) of obstruction, respectively. 
Intra-observer Repeatability on Reporting Lacrimal 
Scintigraphy  Analysis of lacrimal surgeon’s first and second 
LS reports showed a strong intra-observer repeatability values 
for both the type (Kappa=0.66; 95%CI: 0.52-0.8, P<0.001) and 
anatomical location (Kappa=0.69; 95%CI: 0.57-0.8, P<0.001) 
of obstruction. 
Lacrimal Scintigraphy Report Versus Irrigation Test 
Reliability  Reliability proportion of lacrimal surgeon reports 
on the type of obstruction (considering the irrigation test) was 
51% (51/100) including 39% normal, 8% partial obstruction, 
Figure 1 Right intraduct stenosis with left pre-duct obstruction (A), right pre-duct stenosis with normal left side (B), and right pre-sac 
obstruction with normal left side (C) on LS.
Table 1 Comparing 100 LS reports by lacrimal surgeon versus nuclear medicine specialist
Type of obstruction
Anatomical location of obstruction
Lacrimal surgeon Nuclear medicine specialist
Normal Presac Preduct Intraduct Normal Presac Preduct Intraduct
Normal 53 - - - 60 - - -
Partial obstruction - 1 9 9 - 1 2 -
Complete obstruction - 3 24 1 - 2 33 2
Total 53% 4% 33% 10% 60% 3% 35% 2%
LS: Lacrimal scintigraphy.
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and 4% complete obstruction (Table 4) which was significant 
but low (Kappa=0.19; 95%CI: 0.04-0.33; P=0.002). 
However, reliability proportion of lacrimal surgeon reports 
on the location of obstruction (considering the irrigation test) 
was 42% (42/100) including 39% normal and 3% presac 
obstruction (Table 5) which was not significant (Kappa=0.08; 
95% CI: -0.03-0.2; P=0.09).
On the other hand, irrigation test results and LS reports 
by nuclear medicine specialist did not show a significant 
agreement for both the type (Kappa=0.1; 95%CI: -0.02-0.2; 
P=0.05) and anatomical location (Kappa=0.07; 95%CI: -0.05-0.2; 
P=0.13) of obstruction.
DISCUSSION
LS is a simple and low-radiation dose method for assessment 
of LDS which gives a morphological documentation of tear 
flow[6,21-22]. Interpretation of LS could be visual (qualitative) 
or quantitative[6,23]. Visual classifications has been the most 
common type of classification used in previous studies[24] 
and clinical practice. LS usually demonstrate the sac and 
duct obstructions better than canalicular obstructions[24]. 
Wearne et al[19] proposed that many cases with presac 
retention may have a primarily canalicular problem, 
whereas those with preduct or intraduct delay might have an 
abnormally functioning nasolacrimal duct. However, there 
is not an agreement on normative data[15,24]. More than 40% 
of asymptomatic individuals might have abnormalities and 
variability in tracer times of LS[14]. Sagili et al[15] believed that 
interpretation of LS is more an art than pure science.
One study (examining 242 eyes) found poor correlation 
between LS and both patients’ symptoms and clinical 
examination[14]. Therefore, LS interpretation should be 
performed alongside the clinical findings. On the other hand, 
Fard-Esfahani et al[13] found a moderate agreement between 
LS and clinical findings (Kappa=0.52) in the first visit, which 
increased to almost perfect agreement (Kappa=0.86) after 
one year follow up, implying that abnormal LS results in first 
visit may show subtle abnormalities in the LDS which could 
present clinically later on. Poor agreement values between 
irrigation results and LS reports in this study is in accordance 
with previous findings[9-10]. Such observations are the reasons 
why clinicians (including ophthalmologists) are mostly relying 
on irrigation test[25-26].
In the field of medical imaging, literature is mostly focused on 
the accuracy of the imaging systems rather than accuracy of 
interpretation of the images or agreement between the reports 
by different specialties[27-28]. For example, a recently published 
review in diagnostic radiology showed that agreement studies 
are infrequently and sub-optimally reported in the radiology 
literature and are limited[27]. Since different specialties have 
different experiences and background knowledge[28-29], 
consensus image interpretation by different specialties could 
be considered as a solution. Despite its overall positive clinical 
implication, reaching to a consensus is not easy[27]. 
Clinicians (including ophthalmologists) who are involved 
with the management of epiphora sometimes request LS test, 
even though surveys have shown that they are mostly relying 
on irrigation test[25-26]. LS is a simple and low-radiation dose 
method for assessment of LDS which gives a morphological 
documentation of tear flow[6,21-22]. The poor agreement values 
observed between irrigation results and LS reports in this study 
is in accordance with previous findings[9-10] which may justify 
the results of previous surveys in this regard[25-26]. 
Table 2 Agreement of lacrimal surgeon and nuclear medicine on 







  Normal 46 1 6
  Partial obstruction 9 1 9
  Complete obstruction 5 1 22
Table 3 Agreement of lacrimal surgeon and nuclear medicine on 
the anatomical location of obstruction in lacrimal scintigraphy
Type of obstruction
Nuclear medicine specialist
Normal Presac Preduct Intraduct
Lacrimal surgeon
  Normal 46 1 5 1
  Presac 1 0 3 0
  Preduct 7 2 23 1
  Intraduct 6 0 4 0
Table 4 Reliability of lacrimal surgeon’s report (lacrimal scintigraphy) 







  Normal 39 11 15
  Partial obstruction 14 8 9
  Complete obstruction 0 0 4
Table 5 Reliability of lacrimal surgeon’s report (lacrimal 
scintigraphy) on the anatomical location of lacrimal obstruction 
considering the irrigation test
Type of obstruction
Irrigation test
Normal Presac Preduct Intraduct
Lacrimal surgeon
  Normal 39 13 0 1
  Presac  1 3 0 0
  Preduct  20 10 0 3
  Intraduct 5 5 0 0
Reliability of lacrimal scintigraphy
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Results of this study did not show a strong inter-observer 
agreement between lacrimal surgeon and nuclear medicine 
specialists especially in cases with abnormal irrigation test and 
for the location of obstruction. This observation may imply 
that LS of the patients with abnormal irrigation should be re-
reported by a lacrimal surgeon before final decision making. 
In the field of medical imaging, literature is mostly focused on 
the accuracy of the imaging systems rather than accuracy of 
interpretation of the images or agreement between the reports 
by different specialties[27-28]. For example, a recently published 
review in diagnostic radiology showed that agreement studies 
are infrequently and sub-optimally reported in the radiology 
literature and are limited[27]. Since different specialties have 
different experiences and background knowledge[28-29], 
consensus image interpretation by different specialties could 
be considered as a solution. Despite its overall positive 
clinical implication, reaching to a consensus is not easy[27]. 
We suggest constituting consensus groups among nuclear 
medicine specialists and lacrimal surgeons in order to create 
a common language between them (including guidelines) for 
interpretation of LS. Similar guidelines have been published 
for interpretation of orbital imaging like CT scan and MRI[30]. 
There are important questions to be addressed in such a 
consensus group, like “How often did the two specialists agree 
about reporting and how often did they disagree in findings?”, 
“Was their disagreement systematic or a random one?”, “How 
much the observed disagreement was influenced by experience 
or other factors?”[28]. Despite its overall positive clinical 
implication, reaching to a consensus is not easy[27]. 
On limitation of this study was not assessing the intra-
observer repeatability for nuclear medicine specialist who 
was not available for such an aim. This assessment could 
show consistency of interpretation results in comparison to 
the lacrimal surgeon’s report. Furthermore, a larger sample 
size would increase the statistical power. We are aware of that 
the clinical implication of LS in the anophthalmic socket is 
basically different from the seeing eye which was not the aim 
of this study. 
In conclusion, this is the first study on inter-observer agreement 
and intra-observer repeatability of LS in which a moderate 
agreement was found between lacrimal surgeon and nuclear 
medicine specialist. It was substantially decreased in cases with 
abnormal irrigation test and for the location of obstruction. LS 
showed no to slight reliability based on irrigation test. Strong 
level of intra-observer repeatability was found for the lacrimal 
surgeon.
Based on the results, reports of LS should not be a basis for 
management of LDS obstruction. A consensus group of nuclear 
medicine specialists and lacrimal surgeons are recommended 
for delivering a uniform guideline for interpretation of LS.
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